Multivalent IgM scaffold enhances the therapeutic potential of variant-agnostic ACE2 decoys against SARS-CoV-2
Open Access
- 25 May 2023
- journal article
- research article
- Published by Taylor & Francis in mAbs
- Vol. 15 (1) , 2212415
Abstract
As immunological selection for escape mutants continues to give rise to future SARS-CoV-2 variants, novel universal therapeutic strategies against ACE2-dependent viruses are needed. Here we present an IgM-based decavalent ACE2 decoy that has variant-agnostic efficacy. In immuno-, pseudovirus, and live virus assays, IgM ACE2 decoy had potency comparable or superior to leading SARS-CoV-2 IgG-based mAb therapeutics evaluated in the clinic, which were variant-sensitive in their potency. We found that increased ACE2 valency translated into increased apparent affinity for spike protein and superior potency in biological assays when decavalent IgM ACE2 was compared to tetravalent, bivalent, and monovalent ACE2 decoys. Furthermore, a single intranasal dose of IgM ACE2 decoy at 1 mg/kg conferred therapeutic benefit against SARS-CoV-2 Delta variant infection in a hamster model. Taken together, this engineered IgM ACE2 decoy represents a SARS-CoV-2 variant-agnostic therapeutic that leverages avidity to drive enhanced target binding, viral neutralization, and in vivo respiratory protection against SARS-CoV-2.Keywords
Funding Information
- reported there is no funding associated with the work featured
This publication has 77 references indexed in Scilit:
- Cryo-EM structure of the 2019-nCoV spike in the prefusion conformationScience, 2020
- Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCREurosurveillance, 2020
- Predictive Modeling of Influenza Shows the Promise of Applied Evolutionary BiologyTrends in Microbiology, 2018
- A pilot clinical trial of recombinant human angiotensin-converting enzyme 2 in acute respiratory distress syndromeCritical Care, 2017
- Exploiting Mucosal Immunity for Antiviral VaccinesAnnual Review of Immunology, 2016
- Enhancement of antibody-dependent cell-mediated cytotoxicity by endowing IgG with FcαRI (CD89) bindingmAbs, 2015
- Improving biophysical properties of a bispecific antibody scaffold to aid developabilitymAbs, 2013
- Chromatographic behavior of IgM:DNA complexesJournal of Chromatography A, 2011
- Angiotensin converting enzyme-2 confers endothelial protection and attenuates atherosclerosisAmerican Journal of Physiology-Heart and Circulatory Physiology, 2008
- A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus–induced lung injuryNature Medicine, 2005